Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
7
×
detroit blog main
detroit top stories
drugs
7
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
7
×
san francisco blog main
san francisco top stories
7
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
indiana blog main
indiana top stories
national
fda
biotech
roche
startups
abbvie
deals
gene therapy
investing
pfizer
agios pharmaceuticals
american society of hematology
What
bio
drug
fda
roundup
american
annual
approved
ash
big
blood
companies
conference
diego
disease
gathering
largest
medical
san
society
week
admits
ago
ahead
alzheimer’s
asco
assessed
attention
biotech
biotechs
borne
branded
cancer
cancers
choices
classes
combinator
commissioner
communities
consumers
costly
Language
unset
Current search:
drugs
×
cancer
×
" san diego top stories "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More